Last reviewed · How we verify

NCT05023954

mSEP: Testing of Physiological and Immune-metabolic Blood Markers for Maternal Sepsis

Status unknown Last updated 27 August 2021
What this trial tests

trial testing Blood test in Sepsis in 330 participants. Status unknown.

Timeline
12 October 2020
Primary endpoint
1 April 2022
1 September 2022

Quick facts

Lead sponsorCardiff University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment330
Start date12 October 2020
Primary completion1 April 2022
Estimated completion1 September 2022
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Cardiff University

Who can join

Adults 18 to 50, female only, with Sepsis or Maternal Sepsis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective observational cohort study investigating physiological parameters vs biological markers of whole blood in septic and non-septic pregnant woman to predict systemic immune health

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. mSep: investigating physiological and immune-metabolic biomarkers in septic and healthy pregnant women to predict feto-maternal immune health - a prospective observational cohort study protocol.
    Sharma S, Zaher S, Rodrigues PRS, Davies LC, et al · · 2022 · cited 1× · PMID 36115679 · DOI 10.1136/bmjopen-2022-066382

Verify or expand the search:

Other trials of Blood test

Trials testing the same drug.

Other recruiting trials for Sepsis

Currently open trials in the same condition.

Other Cardiff University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05023954.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing